First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate

Vivienne Kahlmann

Center of Excellence for Interstitial Lung Diseases and Sarcoidosis (member of the European Reference Network on Rare Respiratory Diseases), Department of Respiratory Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, the Netherlands

Montse Janssen Bonás

Interstitial Lung Disease Center of Excellence (member of the European Reference Network on Rare Respiratory Diseases), St. Antonius Hospital, Nieuwegein, the Netherlands

Catharina C. Moor

Center of Excellence for Interstitial Lung Diseases and Sarcoidosis (member of the European Reference Network on Rare Respiratory Diseases), Department of Respiratory Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, the Netherlands

Jan C. Grutters

Rémy L.M. Mostard

Department of Respiratory Medicine, Zuyderland Medical Center, Heerlen, the Netherlands

Henricus N.A.J. van Rijswijk

Department of Pulmonary Medicine, Jeroen Bosch Hospital, ’s-Hertogenbosch, the Netherlands

Jan van der Maten

Department of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, the Netherlands

Emiel R. Marges

Department of Pulmonary Medicine, Leiden University Medical Center, Leiden, the Netherlands

Linda A.A. Moonen

Department of Pulmonary Medicine, Rijnstate Hospital, Arnhem, the Netherlands

Maria J. Overbeek

Department of Pulmonary Medicine, Leiden University Medical Center, Leiden, the Netherlands

Bart Koopman

Department of Pulmonary Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam

Daan W. Loth

Department of Pulmonary Medicine, Amphia, Breda, the Netherlands

Esther J. Nossent

Center of Expertise for Interstitial Lung Disease and Sarcoidosis, Department of Pulmonary Medicine, Amsterdam University Medical Center, Amsterdam

Michiel Wagenaar

Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, the Netherlands

Henk Kramer

Department of Pulmonary Medicine, Martini Hospital, Groningen, the Netherlands

Pascal L.M.L. Wielders

Department of Pulmonary Medicine, Catharina Hospital, Eindhoven, the Netherlands

Peter I. Bonta

Center of Expertise for Interstitial Lung Disease and Sarcoidosis, Department of Pulmonary Medicine, Amsterdam University Medical Center, Amsterdam

Stefan Walen

Department of Pulmonary Medicine, Isala Hospital, Zwolle, the Netherlands

Brigitte A.H.A. Bogaarts

Department of Pulmonary Diseases, VieCuri Medical Center, Venlo, the Netherlands

René Kerstens

Orion Statistical Consulting, Hilvarenbeek, the Netherlands

Mayka Overgaauw

Sarcoidosis Patient Association, Alkmaar, the Netherlands

Marcel Veltkamp

Interstitial Lung Disease Center of Excellence (member of the European Reference Network on Rare Respiratory Diseases), St. Antonius Hospital, Nieuwegein, the Netherlands

Marlies S. Wijsenbeek